Long Noncoding RNAs as Emerging Regulators of COVID-19

Area of Science:

• Molecular Biology
• Immunology
• Virology

Background:

• Coronavirus disease 2019 (COVID-19) is a global pandemic with high mortality.
• Existing treatments for COVID-19 include antivirals, monoclonal antibodies, and glucocorticoids.
• Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators in viral infections and immune responses.

Purpose of the Study:

• To review the current findings on the role of lncRNAs in COVID-19 pathogenesis.
• To discuss the mechanisms by which lncRNAs regulate inflammation, immune dysfunction, and thrombosis in SARS-CoV-2 infection.
• To highlight therapeutic challenges and future research directions for lncRNA-based COVID-19 treatments.

Main Methods:

• Literature review and synthesis of existing research on lncRNAs and SARS-CoV-2.
• Analysis of lncRNA involvement in viral gene regulation and host transcriptome changes.
• Examination of lncRNA impact on type I interferon (IFN-1) pathways and immune evasion.

Main Results:

• lncRNAs directly modulate viral replication and pathology by altering host gene expression.
• Some lncRNAs contribute to viral immune escape by suppressing IFN-1, while others enhance antiviral immunity.
• lncRNAs are implicated in the hyperinflammatory response, immune dysregulation, and thrombotic events associated with severe COVID-19.

Conclusions:

• lncRNAs are critical players in the host's response to SARS-CoV-2 infection.
• Targeting lncRNAs presents a promising avenue for developing novel therapeutic strategies against COVID-19.
• Further research into lncRNA mechanisms is essential for advancing COVID-19 treatment.